A single, undetectable, high-sensitivity, cardiac troponin T (hs-cTnT) test in combination with a nonischemic ECG result may effectively rule out acute myocardial infarction in emergency department (ED) patients presenting greater than 3 hours after symptom onset. In the original article, the false-positive rate was published in place of the specificity. These data appear in the supplemental appendix.
Results
Eleven studies were included, with a total of 9,241 patients. Overall acute myocardial infarction prevalence was 15.4%. Of the total included patient population, 30.6% were classified as being at low risk for acute myocardial infarction by a single negative hs-cTnT result and a nonischemic ECG result. Of these patients, 14 (0.5%) received a diagnosis of acute myocardial infarction. In 7 of these cases, the time between symptom onset and blood sampling was less than 3 hours. The pooled performance estimates for Performance of hs-cTnT testing in the assessment of acute myocardial infarction and major adverse cardiac events. 
Commentary
Chest pain is a common ED presentation and associated with high rates of hospital admission and resource use 1 despite a low incidence of acute myocardial infarction. 2 Risk stratification is largely determined by ECG result and cardiac troponin (cTn) measurements; however, conventional cTn assays are limited by a delayed increase of circulating levels leading to recommendations for serial sampling. 2, 3 High-sensitivity cTn assays have enabled measurements not reliably detected with previous assays. 4 The goal of this systematic review was to assess the ability of a single hs-cTnT result in combination with a nonischemic ECG result to safely identify patients at low risk for acute myocardial infarction. The authors performed a comprehensive search and assessed the quality of included studies with a validated instrument (Quality Assessment of Diagnostic Accuracy Studies, version 2). The applicability and generalizability of the results are limited by high heterogeneity and risk of bias. With these limitations in mind, the authors' conclusions that a single negative hs-cTnT result in combination with a nonischemic ECG result may rule out acute myocardial infarction in a "substantial proportion" of patients are reasonable. The data supporting this conclusion may not apply to patients presenting less than 3 hours after symptom onset because the reported sensitivity is lost in this subpopulation.
Current evidence suggests that usual care with conventional cTn assays 5 or a single sensitive troponin assay may be as effective as hs-cTnT when patients are appropriately stratified as being at low risk for acute myocardial infarction. 6 However, owing to a wide practice variation for an "acceptable miss rate" 7 and diverse causes for presenting symptoms, 8 admission for serial cTn and provocative testing is common.
1 Implementation of hscTnT may enable patients to be safely discharged from the ED earlier than in current practice; however, the reduced specificity may negate the benefits of ED throughput by increasing hospital admission, health care spending, and invasive interventions. 9 Establishing protocols for the incorporation of this assay into current practice and further research assessing its effect on patient care and health care systems will improve the use of hs-cTnT. 
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